T1D (type 1 diabetes) is an autoimmune disease characterized by lymphocytic infiltration, or inflammation in pancreatic islets called ‘insulitis.’ Comparatively speaking, T2D (type 2 diabetes) is traditionally characterized by insulin resistance and islet β cell dysfunction; however, a number of studies have clearly demonstrated that chronic tissue inflammation is a key contributing factor to T2D. The NLR (Nod-like receptor) family of innate immune cell sensors such as the NLRP3 inflammasome are implicated in leading to CASP1 activation and subsequent IL1B (interleukin 1, β) and IL18 secretion in T2D. Recent developments reveal a crucial role for the autophagy pathway under conditions of oxidative stress and inflammation. Increasingly, research on autophagy has begun to focus on its role in interacting with inflammatory processes, and thereby how it potentially affects the outcome of disease progression. In this review, we explore the pathophysiological pathways associated with oxidative stress and inflammation in T2D. We also explore how autophagy influences glucose homeostasis by modulating the inflammatory response. We will provide here a perspective on the current research between autophagy, inflammation and T2D.
Autophagy is an intracellular catabolic system, which enables cells to capture cytoplasmic components for degradation within lysosomes. Autophagy is involved in development, differentiation and tissue remodeling in various organisms, and is also implicated in certain diseases. Recent studies demonstrate that autophagy is necessary to maintain architecture and function of pancreatic beta cells. Altered autophagy is also involved in pancreatic beta cell death. Whether autophagy plays a protective or harmful role in diabetes is still not clear. In this review, we will summarize the current knowledge about the role of autophagy in pancreatic beta cell and diabetes.
In pancreatic β-cells, the endoplasmic reticulum (ER) is the crucial site for insulin biosynthesis, as this is where the protein-folding machinery for secretory proteins is localized. Perturbations to ER function of the β-cell, such as those caused by high levels of free fatty acid and insulin resistance, can lead to an imbalance in protein homeostasis and ER stress, which has been recognized as an important mechanism for type 2 diabetes. Macroautophagy (hereafter referred to as autophagy) is activated as a novel signaling pathway in response to ER stress. In this review, we outline the mechanism of ER stress-mediated β-cell death and focus on the role of autophagy in ameliorating ER stress. The development of drugs to take advantage of the potential protective effect of autophagy in ER stress, such as glucagon like peptide-1, will be a promising avenue of investigation.
14 April 2022 in European Journal of Clinical Nutrition
Background: Cardiometabolic multimorbidity (CMM) has emerged as a significant global health challenge. The triglyceride-glucose (TyG) index and a body shape index (ABSI), which are markers of insulin resistance and central obesity, respectively, have each been associated with CMM, but their combined utility remains unclear. This study analyzed the association of cumulative and single-point TyG-ABSI with CMM. Methods: This study included 5334 participants from the China Health and Retirement Longitudinal Study (CHARLS), covering the period from 2011 to 2020. Cumulative TyG-ABSI was derived from data collected in 2011 and 2015. Incident CMM was defined as having at least two of the following: heart disease, stroke, and diabetes. Cox regression models were used to estimate hazard ratios, and restricted cubic splines (RCS) were employed to examine nonlinear associations. Time-dependent receiver operating characteristic (ROC) curves were constructed to compare predictive performance. Subgroup and sensitivity analyses were also performed. Results: Over 9 years of follow-up, 424 participants (7.95%) developed CMM. Those in the highest TyG-ABSI quartile had a 2.46-fold higher risk than those in the lowest quartile. The association varied by sex: cumulative TyG-ABSI showed a nonlinear relationship with a threshold effect in females, whereas in males, only cumulative TyG-ABSI (not the single-point measure) was significant. Cumulative TyG-ABSI demonstrated better 5-year predictive performance than single-point measures. Conclusions: Cumulative TyG-ABSI independently predicts CMM risk across sexes, whereas single-point TyG-ABSI is only predictive in females. Quantifying long-term metabolic burden using cumulative TyG-ABSI offers a practical, noninvasive tool for chronic risk stratification in aging populations. Routine assessment of cumulative TyG-ABSI in clinical and community settings could facilitate early identification of high-risk individuals, enabling targeted preventive interventions to reduce the growing burden of CMM.